Amazon coin set to soar 25X – starting December 16th?

This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024

Margaret A. Horn net worth and biography

Margaret Horn Biography and Net Worth

COO of Revolution Medicines

Peg initially studied pharmacy, but shortly into that five-year educational program decided to advance her education by attending either medical or law school. A lawyer-professor at her pharmacy school tailored an independent legal study course for her, sealing her fate. She completed pharmacy school and then studied law at Villanova Law School. While still in law school, she worked part-time in DuPont’s legal department and subsequently joined the company counseling its pharmaceutical division.

Led by an entrepreneurial spirit and a desire to see more of the country, she moved to San Francisco. Once there, she embarked on a 30-year adventure in biotechnology, working at both large/public companies (Genencor International and Kosan Biosciences) and small, privately held companies (Cogentus and ProLynx). Through years of biotech experience including international strategic transactions, worldwide litigation and multiple public and private financings, Peg’s role evolved from counsel to business and operational leadership positions.

Peg holds a B.S. in pharmacy and a J.D., as well as an executive M.B.A. She is a member of the Pennsylvania and California bars and is a registered patent attorney with the U.S. Patent & Trademark Office. She is a registered pharmacist in Pennsylvania.

What is Margaret A. Horn's net worth?: The estimated net worth of Margaret A. Horn is at least $5.64 million as of December 16th, 2024. Ms. Horn owns 127,991 shares of Revolution Medicines stock worth more than $5,639,283 as of December 21st. This net worth approximation does not reflect any other assets that Ms. Horn may own. Additionally, Ms. Horn receives a salary of $811,080.00 as COO at Revolution Medicines. Learn More about Margaret A. Horn's net worth.
How old is Margaret A. Horn?: Ms. Horn is currently 61 years old. There are 5 older executives and no younger executives at Revolution Medicines. The oldest executive at Revolution Medicines is Dr. Stephen M. Kelsey FRC Path., FRCP, M.D., President of Research & Development, who is 63 years old. Learn More on Margaret A. Horn's age.
What is Margaret A. Horn's salary?: As the COO of Revolution Medicines, Inc., Ms. Horn earns $811,080.00 per year. There are 2 executives that earn more than Ms. Horn. The highest earning executive at Revolution Medicines is Dr. Mark A. Goldsmith Ph.D., CEO, President & Chairman, who commands a salary of $1,120,000.00 per year. Learn More on Margaret A. Horn's salary.
How do I contact Margaret A. Horn?: The corporate mailing address for Ms. Horn and other Revolution Medicines executives is 700 Saginaw Drive, Redwood City CA, 94063. Revolution Medicines can also be reached via phone at 650-481-6801 and via email at [email protected]. Learn More on Margaret A. Horn's contact information.
Has Margaret A. Horn been buying or selling shares of Revolution Medicines?: In the last ninety days, Margaret A. Horn has sold $2,713,536.60 in Revolution Medicines stock. Most recently, Margaret A. Horn sold 4,329 shares of the business's stock in a transaction on Monday, December 16th. The shares were sold at an average price of $45.40, for a transaction totalling $196,536.60. Following the completion of the sale, the chief operating officer now directly owns 127,991 shares of the company's stock, valued at $5,810,791.40. Learn More on Margaret A. Horn's trading history.
Who are Revolution Medicines' active insiders?: Revolution Medicines' insider roster includes Jack Anders (Insider), Jeff Cislini (General Counsel), Mark Goldsmith (Insider), Margaret Horn (COO), Stephen Kelsey (President, Research & Development), Lorence Kim (Director), Vincent Miller (Director), Sushil Patel (Director), Thilo Schroeder (Director), Peter Svennilson (Director), Xiaolin Wang (Insider), and Barbara Weber (Director). Learn More on Revolution Medicines' active insiders.
Are insiders buying or selling shares of Revolution Medicines?: In the last twelve months, Revolution Medicines insiders bought shares 1 times. They purchased a total of 1,304,347 shares worth more than $59,999,962.00. In the last twelve months, insiders at the sold shares 28 times. They sold a total of 271,841 shares worth more than $11,976,056.91. The most recent insider tranaction occured on December, 16th when COO Margaret A Horn sold 4,329 shares worth more than $196,536.60. Insiders at Revolution Medicines own 8.0% of the company. Learn More about insider trades at Revolution Medicines.
Information on this page was last updated on 12/16/2024.

Margaret A. Horn Insider Trading History at Revolution Medicines

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/16/2024	Sell	4,329	$45.40	$196,536.60	127,991
10/11/2024	Sell	50,000	$50.34	$2,517,000.00	132,320
3/18/2024	Sell	2,914	$31.58	$92,024.12	139,553
12/18/2023	Sell	2,993	$25.90	$77,518.70	101,467
12/15/2023	Sell	5,000	$26.64	$133,200.00	104,460
10/16/2023	Sell	25,000	$33.95	$848,750.00	96,960
9/18/2023	Sell	2,514	$31.31	$78,713.34	96,960
9/15/2023	Sell	5,000	$32.08	$160,400.00	99,474
8/31/2023	Sell	10,000	$34.05	$340,500.00	99,474
8/15/2023	Sell	5,000	$30.53	$152,650.00	99,474
3/17/2023	Sell	1,230	$21.78	$26,789.40	100,062
10/31/2022	Sell	17,767	$20.41	$362,624.47	17,767
10/26/2022	Sell	17,768	$20.15	$358,025.20	35,534
3/17/2022	Sell	321	$18.61	$5,973.81
10/2/2020	Sell	70,000	$35.08	$2,455,600.00	10,454

Margaret A. Horn Buying and Selling Activity at Revolution Medicines

Revolution Medicines Company Overview

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Today's Range

Now: $44.06

$42.53

$44.22

50 Day Range

MA: $51.85

$42.97

$60.60

2 Week Range

Now: $44.06

$25.91

$62.40

Volume

2,673,471 shs

Average Volume

1,401,604 shs

Market Capitalization

$7.41 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4

Amazon coin set to soar 25X – starting December 16th?

From True Market Insiders | Ad

>3-Cent Amazon Coin<

Margaret Horn Biography and Net Worth

What is Margaret A. Horn's net worth?

How old is Margaret A. Horn?

What is Margaret A. Horn's salary?

How do I contact Margaret A. Horn?

Has Margaret A. Horn been buying or selling shares of Revolution Medicines?

Who are Revolution Medicines' active insiders?

Are insiders buying or selling shares of Revolution Medicines?